JP2010018645A - Post-foaming aerosol composition and aerosol product using the same - Google Patents
Post-foaming aerosol composition and aerosol product using the same Download PDFInfo
- Publication number
- JP2010018645A JP2010018645A JP2008177745A JP2008177745A JP2010018645A JP 2010018645 A JP2010018645 A JP 2010018645A JP 2008177745 A JP2008177745 A JP 2008177745A JP 2008177745 A JP2008177745 A JP 2008177745A JP 2010018645 A JP2010018645 A JP 2010018645A
- Authority
- JP
- Japan
- Prior art keywords
- post
- cellulose
- foaming
- aerosol composition
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000443 aerosol Substances 0.000 title claims abstract description 126
- 239000000203 mixture Substances 0.000 title claims abstract description 99
- 238000005187 foaming Methods 0.000 title claims abstract description 82
- 229920002678 cellulose Polymers 0.000 claims abstract description 111
- 239000001913 cellulose Substances 0.000 claims abstract description 111
- 239000002245 particle Substances 0.000 claims abstract description 25
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 22
- 239000003380 propellant Substances 0.000 claims abstract description 22
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 18
- 239000010419 fine particle Substances 0.000 claims description 58
- 238000002425 crystallisation Methods 0.000 claims description 20
- 230000008025 crystallization Effects 0.000 claims description 20
- 239000011859 microparticle Substances 0.000 abstract description 2
- -1 propylene glycol fatty acid ester Chemical class 0.000 description 42
- 229920001296 polysiloxane Polymers 0.000 description 28
- 239000000047 product Substances 0.000 description 21
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- 229930195729 fatty acid Natural products 0.000 description 16
- 239000006185 dispersion Substances 0.000 description 14
- 239000006260 foam Substances 0.000 description 13
- 235000002639 sodium chloride Nutrition 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 238000002347 injection Methods 0.000 description 12
- 239000007924 injection Substances 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- 239000013078 crystal Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000004166 Lanolin Substances 0.000 description 9
- 235000019388 lanolin Nutrition 0.000 description 9
- 229940039717 lanolin Drugs 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000002917 insecticide Substances 0.000 description 7
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 230000009974 thixotropic effect Effects 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 239000002612 dispersion medium Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- 229920000875 Dissolving pulp Polymers 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 210000002826 placenta Anatomy 0.000 description 4
- 238000001226 reprecipitation Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 235000011399 aloe vera Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 241000772415 Neovison vison Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- AQEDFGUKQJUMBV-UHFFFAOYSA-N copper;ethane-1,2-diamine Chemical compound [Cu].NCCN AQEDFGUKQJUMBV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PIGTXFOGKFOFTO-FVFWYJKVSA-N (2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,8R,8aR,12aS,14aR,14bR)-8a-carboxy-4-formyl-8-hydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)C[C@@H](O)[C@]1(CCC(C[C@H]14)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O PIGTXFOGKFOFTO-FVFWYJKVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- ZTBOHPVCZAACCS-UHFFFAOYSA-N 1,5,5-trichlorocyclohex-3-ene-1,2-diol Chemical compound OC1C=CC(Cl)(Cl)CC1(O)Cl ZTBOHPVCZAACCS-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- DJCYDDALXPHSHR-UHFFFAOYSA-N 2-(2-propoxyethoxy)ethanol Chemical compound CCCOCCOCCO DJCYDDALXPHSHR-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- KHPFIDDXCRYEHS-UHFFFAOYSA-N 2-butyloctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)CCCC KHPFIDDXCRYEHS-UHFFFAOYSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- AHDXKQAZDADIGD-UHFFFAOYSA-N 2-propan-2-ylhexadecanoic acid Chemical compound CCCCCCCCCCCCCCC(C(C)C)C(O)=O AHDXKQAZDADIGD-UHFFFAOYSA-N 0.000 description 1
- QUJHRAJAGNMYKJ-UHFFFAOYSA-N 2-propan-2-yloctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(C(C)C)C(O)=O QUJHRAJAGNMYKJ-UHFFFAOYSA-N 0.000 description 1
- CKPOABDCSSXDCY-UHFFFAOYSA-N 2-propan-2-yltetradecanoic acid Chemical compound CCCCCCCCCCCCC(C(C)C)C(O)=O CKPOABDCSSXDCY-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- BIQUJLSTLXZGTO-UHFFFAOYSA-N C(CC)(=O)O.C(C)C=1C(=C(C(=C2N(C(C(N2)=O)=O)CCCCCC)OC)C=CC1)OC Chemical compound C(CC)(=O)O.C(C)C=1C(=C(C(=C2N(C(C(N2)=O)=O)CCCCCC)OC)C=CC1)OC BIQUJLSTLXZGTO-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000218228 Humulus Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- JSCQSBGXKRTPHZ-UHFFFAOYSA-N Mucidin Natural products COC=C(C(=O)OC)C(C)=CC=CC1=CC=CC=C1 JSCQSBGXKRTPHZ-UHFFFAOYSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- WAZRMMCZPHCRFW-UHFFFAOYSA-L S(=O)(=O)(O)S(=O)(=O)[O-].[Zn+2].S(=O)(=O)(O)S(=O)(=O)[O-] Chemical compound S(=O)(=O)(O)S(=O)(=O)[O-].[Zn+2].S(=O)(=O)(O)S(=O)(=O)[O-] WAZRMMCZPHCRFW-UHFFFAOYSA-L 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002197 Sodium polyaspartate Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- JSCQSBGXKRTPHZ-WMSPMLHYSA-N Strobilurin A Natural products COC=C(/C(=C/C=C/c1ccccc1)/C)C(=O)OC JSCQSBGXKRTPHZ-WMSPMLHYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 239000005843 Thiram Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical class CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- RKFMOTBTFHXWCM-UHFFFAOYSA-M [AlH2]O Chemical compound [AlH2]O RKFMOTBTFHXWCM-UHFFFAOYSA-M 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960000510 ammonia Drugs 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229960002645 boric acid Drugs 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 description 1
- LFHISGNCFUNFFM-UHFFFAOYSA-N chloropicrin Chemical compound [O-][N+](=O)C(Cl)(Cl)Cl LFHISGNCFUNFFM-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000005338 frosted glass Substances 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- ZFSXZJXLKAJIGS-UHFFFAOYSA-N halocarban Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=CC(Cl)=CC=2)=C1 ZFSXZJXLKAJIGS-UHFFFAOYSA-N 0.000 description 1
- 229950006625 halocarban Drugs 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- DLINORNFHVEIFE-UHFFFAOYSA-N hydrogen peroxide;zinc Chemical compound [Zn].OO DLINORNFHVEIFE-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- VLHZUYUOEGBBJB-UHFFFAOYSA-N hydroxy stearic acid Natural products OCCCCCCCCCCCCCCCCCC(O)=O VLHZUYUOEGBBJB-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- YETXGSGCWODRAA-UHFFFAOYSA-N isopropyl palmitic acid Natural products CC(C)CCCCCCCCCCCCCCCC(O)=O YETXGSGCWODRAA-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- JSCQSBGXKRTPHZ-SYKZHUKTSA-N mucidin Chemical compound CO\C=C(\C(=O)OC)/C(/C)=C\C=C\C1=CC=CC=C1 JSCQSBGXKRTPHZ-SYKZHUKTSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 239000004306 orthophenyl phenol Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 238000004736 wide-angle X-ray diffraction Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
本発明は、後発泡性エアゾール組成物および該後発泡性エアゾール組成物を用いるエアゾール製品に関する。 The present invention relates to a post-foaming aerosol composition and an aerosol product using the post-foaming aerosol composition.
後発泡性エアゾール組成物は、噴射された直後に急激に発泡せず、噴射された後に徐々に発泡するものであり、様々な分野で用いられている。例えば、化粧品分野、外用医薬品分野、防虫剤分野などでエアゾール製品の内容物として用いられている。 The post-foaming aerosol composition does not rapidly foam immediately after being sprayed, but gradually foams after being sprayed, and is used in various fields. For example, it is used as the contents of aerosol products in the cosmetics field, topical medicine field, insect repellent field, and the like.
従来、この種の後発泡性エアゾール組成物としては、様々な種類のものが知られ、例えば、石ケンと水溶性ゲル化剤が配合されたもの(特許文献1)、カルボキシビニルポリマーなどの高分子が配合されたもの(特許文献2)、比較的多量のオイルと特定の沸点を有するアルカンとが配合されたもの(特許文献3)などが知られている。 Conventionally, as this type of post-foaming aerosol composition, various types are known, for example, a combination of soap and a water-soluble gelling agent (Patent Document 1), a high carboxyvinyl polymer and the like. Known are those in which molecules are blended (Patent Document 2) and those in which a relatively large amount of oil and alkane having a specific boiling point are blended (Patent Document 3).
しかしながら、このような従来の後発泡性エアゾール組成物は、良好な噴霧性、後発泡性、良好な泡もち性といった優れた噴射性能を有し得るものの、エアゾール容器のなかで流動性を有するものであり、エアゾール容器を上下反対にして噴射する場合、良好に噴射されないという問題がある。具体的には、容器内に装着されたディップチューブを通ってエアゾール組成物が外部に噴射される通常のエアゾール容器を上下反対にする場合、内容物であるエアゾール組成物がエアゾール容器の噴射口付近に移動するため、エアゾール容器の底部付近にあるディップチューブの開口部からエアゾール組成物が供給されず、エアゾール組成物が良好に噴射されないという問題がある。 However, such a conventional post-foaming aerosol composition may have excellent jetting performance such as good sprayability, post-foaming property, and good foaming property, but has fluidity in an aerosol container. In the case of injecting the aerosol container upside down, there is a problem that it is not injected well. Specifically, when a normal aerosol container in which the aerosol composition is sprayed to the outside through a dip tube mounted in the container is turned upside down, the content of the aerosol composition is near the spray port of the aerosol container Therefore, there is a problem in that the aerosol composition is not supplied from the opening of the dip tube near the bottom of the aerosol container and the aerosol composition is not jetted well.
これに対して、後発泡性エアゾール組成物は、粘性を高めることによって流動しにくくなり得るが、粘性が高められた後発泡性エアゾール組成物は、ディップチューブを通りにくくなるため、噴射自体が不可能になり得るという問題がある。 On the other hand, the post-foaming aerosol composition can be made difficult to flow by increasing the viscosity, but the post-foaming aerosol composition having the increased viscosity becomes difficult to pass through the dip tube, so that the injection itself is not effective. There is a problem that can be possible.
そこで、エアゾール容器を上下反対にする場合であっても流動せず、しかも噴射可能であり、且つ良好な噴霧性、後発泡性、良好な泡もち性といった優れた噴射性能を有する後発泡性エアゾール組成物が要望されている。 Therefore, even when the aerosol container is turned upside down, it does not flow, and it can be jetted, and it is a post-foaming aerosol that has excellent spraying performance such as good sprayability, post-foaming property, and good foaming property. There is a need for a composition.
本発明は、上記の問題点、要望点等に鑑み、流動しにくく、しかも優れた噴射性能を有する後発泡性エアゾール組成物を提供することを課題とする。また、斯かる後発泡性エアゾール組成物を用いたエアゾール製品を提供することを別の課題とする。 An object of the present invention is to provide a post-foaming aerosol composition that is difficult to flow and has excellent jetting performance in view of the above-described problems and demands. Another object is to provide an aerosol product using such a post-foaming aerosol composition.
上記課題を解決すべく、本発明に係る後発泡性エアゾール組成物は、平均粒子径が5μm以下で、平均重合度(DP)が100以下で、結晶化率が50%以下であるセルロースの微粒子と、非イオン界面活性剤と、噴射剤とを含有する後発泡性エアゾール組成物であって、前記非イオン界面活性剤が0.15〜1.5重量%含有されていることを特徴とする。 In order to solve the above problems, the post-foaming aerosol composition according to the present invention has an average particle size of 5 μm or less, an average degree of polymerization (DP) of 100 or less, and a crystallization rate of 50% or less. And a non-foaming aerosol composition containing a nonionic surfactant and a propellant, wherein the nonionic surfactant is contained in an amount of 0.15 to 1.5% by weight. .
上記構成からなる後発泡性エアゾール組成物によれば、平均粒子径が5μm以下で、平均重合度(DP)が100以下で、結晶化率が50%以下であるセルロースの微粒子が含有されているため、前記後発泡性エアゾール組成物は、比較的低いずり応力では粘度が低下しにくい一方で、噴射剤の圧力と外気の圧力との圧力差に起因する比較的高いずり応力によって粘度が急激に低下するチクソトロピー性を有し得る。従って、流動しにくいにもかかわらず良好に噴出され、しかも噴出された後は再び粘度が上昇し被噴射物の表面に保持され得る。また、前記セルロースの微粒子が含有されているため、前記後発泡性エアゾール組成物が噴射された直後における噴射剤の急激な膨張が抑制され、噴射された後に噴射剤が比較的低速度で膨張し始めることができる。さらに、前記非イオン界面活性剤が0.15〜1.5重量%含有されているため、前記後発泡性エアゾール組成物が噴射された後に泡が生じ、さらには、前記セルロースの微粒子により生じた泡が破泡しにくくなる。 According to the post-foaming aerosol composition having the above structure, cellulose fine particles having an average particle diameter of 5 μm or less, an average degree of polymerization (DP) of 100 or less, and a crystallization rate of 50% or less are contained. Therefore, the post-foaming aerosol composition is less likely to decrease in viscosity at a relatively low shear stress, but rapidly increases in viscosity due to a relatively high shear stress resulting from a pressure difference between the pressure of the propellant and the pressure of the outside air. It may have reduced thixotropy. Therefore, although it is hard to flow, it is ejected well, and after it is ejected, the viscosity rises again and can be held on the surface of the object to be ejected. Further, since the cellulose fine particles are contained, rapid expansion of the propellant immediately after the post-foaming aerosol composition is injected is suppressed, and the propellant expands at a relatively low speed after being injected. You can start. Furthermore, since the nonionic surfactant is contained in an amount of 0.15 to 1.5% by weight, bubbles are generated after the post-foaming aerosol composition is injected, and further, the fine particles of cellulose are generated. Bubbles are hard to break.
本発明に係る後発泡性エアゾール組成物は、前記セルロースの微粒子が0.35〜1.25重量%含有されていることが好ましい。
前記セルロースの微粒子が0.35〜1.25重量%含有されていることにより、上述したチクソトロピー性がより顕著になるという利点がある。
The post-foaming aerosol composition according to the present invention preferably contains 0.35 to 1.25% by weight of the cellulose fine particles.
When the cellulose fine particles are contained in an amount of 0.35 to 1.25% by weight, there is an advantage that the above-described thixotropic property becomes more remarkable.
本発明に係るエアゾール製品は、平均粒子径が5μm以下で、平均重合度(DP)が100以下で、結晶化率が50%以下であるセルロースの微粒子と、非イオン界面活性剤と噴射剤とを含有し、前記非イオン界面活性剤が0.15〜1.5重量%含有されている後発泡性エアゾール組成物がエアゾール容器に充填されていることを特徴とする。 The aerosol product according to the present invention comprises cellulose fine particles having an average particle size of 5 μm or less, an average degree of polymerization (DP) of 100 or less, and a crystallization rate of 50% or less, a nonionic surfactant and a propellant. And the non-ionic surfactant is contained in an amount of 0.15 to 1.5% by weight, and a foamable aerosol composition is filled in an aerosol container.
本発明の後発泡性エアゾール組成物は、チクソトロピー性を有するため、流動性しにくいにもかかわらず良好に噴出され、しかも噴出された後は再び粘度が上昇し被噴射物の表面に保持され得る。また、前記後発泡性エアゾール組成物が噴射された直後の噴射剤の急激な膨張が抑制され、噴射された後に噴射剤が比較的低速度で膨張し始め、これに伴って泡が生じる。しかも、生じた泡が破泡しにくい。従って、本発明の後発泡性エアゾール組成物は、流動しにくく、しかも優れた噴射性能を有するという効果を奏する。 The post-foaming aerosol composition of the present invention has thixotropic properties, so that it is ejected well despite being difficult to flow, and after being ejected, the viscosity increases again and can be held on the surface of the object to be ejected. . Further, rapid expansion of the propellant immediately after the post-foaming aerosol composition is injected is suppressed, and after the injection, the propellant starts to expand at a relatively low speed, and bubbles are generated accordingly. Moreover, the generated bubbles are difficult to break. Therefore, the post-foaming aerosol composition of the present invention has the effect of being difficult to flow and having excellent jetting performance.
以下、本発明の後発泡性エアゾール組成物の一実施形態について説明する。 Hereinafter, one embodiment of the post-foaming aerosol composition of the present invention will be described.
本実施形態の後発泡性エアゾール組成物は、平均粒子径が5μm以下で、平均重合度(DP)が100以下で、結晶化率が50%以下であるセルロースの微粒子と、非イオン界面活性剤と、噴射剤とを含有する後発泡性エアゾール組成物であって、前記非イオン界面活性剤が0.15〜1.5重量%含有されているものである。 The post-foaming aerosol composition of the present embodiment comprises cellulose fine particles having an average particle diameter of 5 μm or less, an average degree of polymerization (DP) of 100 or less, and a crystallization rate of 50% or less, and a nonionic surfactant And a post-foaming aerosol composition containing a propellant, wherein the nonionic surfactant is contained in an amount of 0.15 to 1.5% by weight.
前記セルロースは、平均重合度(DP)が100以下である。好ましくは、平均重合度(DP)が10以上100以下であり、より好ましくは20以上50以下である。
前記セルロースの平均重合度(DP)が100を超える場合には、前記セルロースの微粒子が前記後発泡性エアゾール組成物中で均一に分散しにくく、前記後発泡性エアゾール組成物が流動しやすくなり、安定性に乏しいものとなるおそれがある。
The cellulose has an average degree of polymerization (DP) of 100 or less. The average degree of polymerization (DP) is preferably 10 or more and 100 or less, more preferably 20 or more and 50 or less.
When the average degree of polymerization (DP) of the cellulose exceeds 100, the cellulose fine particles are difficult to uniformly disperse in the post-foaming aerosol composition, and the post-foaming aerosol composition is likely to flow, There is a risk of poor stability.
前記セルロースの平均重合度(DP)が50以下であることにより、前記セルロースの微粒子が前記後発泡性エアゾール組成物中でより均一に分散し会合性に優れた分散体が得られるため、前記後発泡性エアゾール組成物がより流動しにくくなり、分散安定性がより高まり得るという利点がある。
また、前記セルロースの平均重合度(DP)が10以上であることにより、前記セルロース微粒子の水溶性が低下し、流動性を抑制し得る微粒子として機能しやすくなるため、前記後発泡性エアゾール組成物の流動性がより低下し、前記後発泡性エアゾール組成物のチクソトロピー性がより向上するという利点がある。
When the average degree of polymerization (DP) of the cellulose is 50 or less, the cellulose fine particles are more uniformly dispersed in the post-foamable aerosol composition, and a dispersion having excellent associative properties is obtained. There is an advantage that the foamable aerosol composition becomes more difficult to flow and the dispersion stability can be further increased.
In addition, since the cellulose has an average degree of polymerization (DP) of 10 or more, the water-solubility of the cellulose fine particles is lowered, and the post-foamable aerosol composition is easily functioned as fine particles capable of suppressing fluidity. There is an advantage that the fluidity of the post-foaming aerosol composition is further improved and the thixotropy of the post-foaming aerosol composition is further improved.
前記セルロースの平均重合度(DP)の調整は、原料となる天然セルロース又は再生セルロースの加水分解処理の程度を調整することによりなし得る。 The average degree of polymerization (DP) of the cellulose can be adjusted by adjusting the degree of hydrolysis of natural cellulose or regenerated cellulose as a raw material.
尚、前記セルロースの平均重合度(DP)は、下記実施例に記載された方法により測定されるものである。 The average degree of polymerization (DP) of the cellulose is measured by the method described in the following examples.
前記セルロースは、結晶化率が50%以下である。好ましくは、結晶化率が30%以下であり、より好ましくは1〜30%である。
前記セルロースの結晶化率が50%を超える場合には、前記セルロースの微粒子が前記後発泡性エアゾール組成物中で均一に分散しにくくなるおそれがある。
The cellulose has a crystallization rate of 50% or less. The crystallization rate is preferably 30% or less, more preferably 1 to 30%.
When the crystallization rate of the cellulose exceeds 50%, the cellulose fine particles may be difficult to uniformly disperse in the post-foamable aerosol composition.
前記セルロースの結晶化率が30%以下であることにより、前記セルロースの微粒子が前記後発泡性エアゾール組成物中でより均一に分散しやすくなるという利点がある。また、前記セルロースの結晶化率が1%以上であることにより、前記セルロース微粒子の水溶性が低下し、流動性を抑制し得る微粒子として機能しやすくなるため、前記後発泡性エアゾール組成物の流動性がより低下し、前記後発泡性エアゾール組成物のチクソトロピー性がより向上するという利点がある。 When the crystallization rate of the cellulose is 30% or less, there is an advantage that the fine particles of cellulose are more easily dispersed more uniformly in the post-foamable aerosol composition. Further, when the crystallization rate of the cellulose is 1% or more, the water-solubility of the cellulose fine particles is lowered, and the cellulose fine particles can easily function as fine particles capable of suppressing fluidity. Therefore, the flow of the post-foamable aerosol composition The properties are further reduced, and the thixotropy of the post-foaming aerosol composition is further improved.
また、前記セルロースの結晶化率におけるI型結晶成分及びII型結晶成分の割合は、特に限定されるものではないが、I型結晶成分の量が好ましくは10%以下、より好ましくは6%以下であり、II型結晶成分の量が好ましくは40%以下、好ましくは30%以下である。 Further, the ratio of the I-type crystal component and the II-type crystal component in the crystallization rate of the cellulose is not particularly limited, but the amount of the I-type crystal component is preferably 10% or less, more preferably 6% or less. The amount of type II crystal component is preferably 40% or less, preferably 30% or less.
前記セルロースの結晶化率を調整するため、原料セルロースの結晶化率を調整する方法としては、例えば、セルロースを溶解させうる溶媒(硫酸、ジメチルアセトアミド、銅エチレンジアミン錯体)等を適宜選択する方法、セルロースを溶解させうる溶媒の量を調整する方法、セルロースを溶解させうる溶媒にセルロースを一旦溶解させてその溶解時間を調整する方法、その後セルロースを再沈殿によって再生させるときの溶媒の種類や量を適宜選択する方法などが挙げられる。具体的には、例えば、セルロースを溶解させうる溶媒にセルロースを溶解させる時間を長くすると前記セルロースの結晶化率が低下し、セルロースを再沈殿によって再生させるときの溶媒の量を多くすると前記セルロースの結晶化率が低下し得る。 In order to adjust the crystallization rate of the cellulose, as a method of adjusting the crystallization rate of the raw material cellulose, for example, a method of appropriately selecting a solvent capable of dissolving cellulose (sulfuric acid, dimethylacetamide, copper ethylenediamine complex), cellulose The method of adjusting the amount of the solvent capable of dissolving the cellulose, the method of adjusting the dissolution time after dissolving the cellulose once in the solvent capable of dissolving the cellulose, and then the type and amount of the solvent when regenerating the cellulose by reprecipitation The method of selection etc. are mentioned. Specifically, for example, if the time for dissolving cellulose in a solvent capable of dissolving cellulose is lengthened, the crystallization rate of the cellulose decreases, and if the amount of the solvent when regenerating the cellulose by reprecipitation is increased, the cellulose The crystallization rate can be reduced.
尚、前記セルロースの結晶化率は、下記実施例に記載された方法により測定されるものである。 In addition, the crystallization rate of the said cellulose is measured by the method described in the following Example.
前記セルロースの微粒子としては、前記セルロースのみで構成されたセルロース微粒子が挙げられる。また、前記セルロースを少なくとも一部に有して構成されたセルロース微粒子も挙げられる。 Examples of the cellulose fine particles include cellulose fine particles composed only of the cellulose. Moreover, the cellulose fine particle comprised by having the said cellulose at least in part is also mentioned.
前記セルロースの微粒子は、平均粒子径が5μm以下である。好ましくは、平均粒子径が5〜500nmであり、より好ましくは5〜200nmである。
前記セルロースの微粒子の平均粒子径が5μmを超える場合、分散媒体中で直ちに沈殿し、流動性が高まり、チクソトロピー性が低下する。従って、前記後発泡性エアゾール組成物が充填されたエアゾール容器を上下反対にして噴射しようとしても前記後発泡性エアゾール組成物が流動し、噴射できなくなるおそれがある。
前記セルロースの微粒子の平均粒子径が5nm以上であることにより、前記セルロースの微粒子を製造時における微粒子の捕集効率が低下しにくいという利点がある。また、流動性を抑制し得る微粒子として機能しやすくなるため、前記後発泡性エアゾール組成物の流動性がより低下し、前記後発泡性エアゾール組成物のチクソトロピー性がより向上するという利点がある。また、前記セルロースの微粒子の平均粒子径が500nm以下であることにより、前記後発泡性エアゾール組成物の噴霧状態がより良好になり、噴射された後の泡もちがより良好になるという利点がある。
The cellulose fine particles have an average particle size of 5 μm or less. The average particle size is preferably 5 to 500 nm, more preferably 5 to 200 nm.
When the average particle size of the cellulose fine particles exceeds 5 μm, it immediately precipitates in the dispersion medium, the fluidity increases, and the thixotropy decreases. Therefore, even if an aerosol container filled with the post-foaming aerosol composition is to be jetted upside down, the post-foaming aerosol composition may flow and cannot be jetted.
When the average particle diameter of the cellulose fine particles is 5 nm or more, there is an advantage that the collection efficiency of the fine particles at the time of producing the cellulose fine particles is hardly lowered. Moreover, since it becomes easy to function as microparticles | fine-particles which can suppress fluidity | liquidity, the fluidity | liquidity of the said post-foamable aerosol composition falls more and there exists an advantage that the thixotropic property of the said post-foamable aerosol composition improves more. Moreover, when the average particle diameter of the cellulose fine particles is 500 nm or less, there is an advantage that the spray state of the post-foaming aerosol composition becomes better, and the foaminess after being injected becomes better. .
前記セルロースの微粒子の平均粒子径は、例えば、前記セルロースの微粒子を超高圧ホモジナイザーなどによって水中で分散させるときのせん断力、せん断力を与える回数等を変えることにより調整できる。具体的には、せん断力を大きくし、せん断力を与える回数を増やすことにより、前記セルロースの微粒子の平均粒子径を小さくすることができ、せん断力を小さくし、せん断力を与える回数を少なくすることにより、前記セルロースの微粒子の平均粒子径を大きくすることができる。 The average particle diameter of the cellulose fine particles can be adjusted, for example, by changing the shearing force when the cellulose fine particles are dispersed in water with an ultrahigh pressure homogenizer, the number of times the shearing force is applied, and the like. Specifically, by increasing the shear force and increasing the number of times the shear force is applied, the average particle size of the cellulose fine particles can be reduced, the shear force is reduced, and the number of times the shear force is applied is reduced. As a result, the average particle size of the cellulose fine particles can be increased.
尚、前記セルロースの微粒子の平均粒子径は、下記実施例に記載された方法により測定されるものである。 The average particle diameter of the cellulose fine particles is measured by the method described in the following examples.
前記セルロースの微粒子は、前記後発泡性エアゾール組成物に0.35重量%以上含有されていることが好ましく、0.40重量%以上含有されていることがより好ましく、0.60重量%以上含有されていることがさらに好ましい。また、1.25重量%以下含有されていることが好ましく、1.0重量%以下含有されていることがより好ましい。
前記セルロースの微粒子が0.35重量%以上含有されていることにより、前記後発泡性エアゾール組成物がより流動しにくくなり、上述したチクソトロピー性がより顕著になるという利点があり、1.25重量%以下含有されていることにより、前記後発泡性エアゾール組成物がより噴射されやすくなり、上述したチクソトロピー性がより顕著になるという利点がある。
The cellulose fine particles are preferably contained in the post-foamable aerosol composition in an amount of 0.35% by weight or more, more preferably 0.40% by weight or more, and 0.60% by weight or more. More preferably. Moreover, it is preferable to contain 1.25 weight% or less, and it is more preferable to contain 1.0 weight% or less.
When the cellulose fine particles are contained in an amount of 0.35% by weight or more, there is an advantage that the post-foaming aerosol composition is more difficult to flow and the above-described thixotropic property becomes more remarkable, and 1.25% by weight. % Or less, there is an advantage that the post-foaming aerosol composition is more easily sprayed and the thixotropy described above becomes more remarkable.
本実施形態の後発泡性エアゾール組成物は、前記セルロースの微粒子が含有されているため、比較的低いずり応力では粘度が低下しにくい一方で、噴射剤の圧力と外気の圧力との圧力差に起因する比較的高いずり応力によって粘度が急激に低下するチクソトロピー性を有し得る。従って、流動しにくいにもかかわらず良好に噴出され、しかも噴出された後は再び粘度が上昇し被噴射物の表面に保持され得る。即ち、噴射時には低粘度化して良好に噴射され、噴出後に応力が低下すると再び粘度が上昇し、被噴射物表面での組成物の液だれが起こり難い。
Since the post-foaming aerosol composition of the present embodiment contains the fine particles of cellulose, the viscosity is unlikely to decrease at a relatively low shear stress, while the pressure difference between the pressure of the propellant and the pressure of the outside air is reduced. It may have thixotropy in which the viscosity rapidly decreases due to the relatively high shear stress resulting therefrom. Therefore, although it is hard to flow, it is ejected well, and after it is ejected, the viscosity rises again and can be held on the surface of the object to be ejected. That is, when jetting, the viscosity is lowered and jetted satisfactorily. When the stress decreases after jetting, the viscosity rises again, and the composition does not easily drip on the surface of the jetted object.
なお、本実施形態の後発泡性エアゾール組成物において“流動しにくい”とは、詳しくは、容器に入れられた後発泡性エアゾール組成物が上下反対にされた時のように、比較的低いずり応力を受けるときに流動しにくいことを意味している。 In addition, in the post-foaming aerosol composition of this embodiment, “difficult to flow” specifically refers to a relatively low shear, such as when the foaming aerosol composition is turned upside down after being placed in a container. It means that it is difficult to flow when subjected to stress.
前記非イオン界面活性剤は、前記後発泡性エアゾール組成物に0.15〜1.5重量%含有されている。 The nonionic surfactant is contained in the post-foaming aerosol composition in an amount of 0.15 to 1.5% by weight.
本実施形態の後発泡性エアゾール組成物は、前記非イオン界面活性剤が0.15〜1.5重量%含有されているため、前記後発泡性エアゾール組成物が噴射された後の噴射剤の膨張に伴って泡が生じ得る。
しかも、本実施形態の後発泡性エアゾール組成物は、前記セルロースの微粒子をも含有されているため、噴射された直後における噴射剤の急激な膨張が抑制され、噴射された後に噴射剤が比較的低速度で膨張し始め得ることに伴い、前記非イオン界面活性剤によって泡を生じ、後発泡性を示す。さらには、生じた泡の破泡が前記セルロースの微粒子により抑制され、泡もちも良好となる。
また、前記非イオン界面活性剤の配合量が1.5重量%以下であるため、前記セルロースの微粒子によるチクソトロピー性の発現が阻害されにくく、本実施形態の後発泡性エアゾール組成物が流動しにくい。
Since the non-foaming aerosol composition of the present embodiment contains 0.15 to 1.5% by weight of the nonionic surfactant, the propellant after the post-foaming aerosol composition is jetted. Bubbles can form with expansion.
Moreover, since the post-foaming aerosol composition of the present embodiment also contains the cellulose fine particles, rapid expansion of the propellant immediately after being jetted is suppressed, and the propellant is relatively comparative after being jetted. Along with being able to start expanding at a low speed, bubbles are generated by the nonionic surfactant and exhibit post-foaming properties. Furthermore, the foam breakage of the generated foam is suppressed by the fine particles of cellulose, and the foam is also good.
Further, since the blending amount of the nonionic surfactant is 1.5% by weight or less, the expression of thixotropy by the cellulose fine particles is hardly inhibited, and the post-foaming aerosol composition of this embodiment is difficult to flow. .
前記非イオン性界面活性剤としては、プロピレングリコール脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリエーテル変性シリコーン等が挙げられる。これらは、1種が単独で、又は2種以上が組み合わされて用いられ得る。
なかでも、起泡性が良好で、前記セルロース微粒子によるチクソトロピー性の発現が阻害されにくいという点、前記セルロース微粒子と液化ガスなどの噴射剤とを安定的に分散させ得るという点で、ポリオキシエチレン硬化ヒマシ油、ポリグリセリン脂肪酸エステルとしてのイソステアリン酸デカグリセリルが好ましい。
Examples of the nonionic surfactant include propylene glycol fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene Examples include sorbite fatty acid ester, polyethylene glycol fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, and polyether-modified silicone. These may be used singly or in combination of two or more.
Among them, polyoxyethylene is preferable in that it has good foaming properties and is difficult to inhibit thixotropic expression by the cellulose fine particles, and can stably disperse the cellulose fine particles and a propellant such as a liquefied gas. Hardened castor oil and decaglyceryl isostearate as polyglycerin fatty acid ester are preferred.
前記噴射剤としては、通常、プロパン及びブタンを含む液化ガス(LPG)が挙げられる。他にも、ジメチルエーテル、二酸化炭素、窒素(N2)、アルゴン、酸素(O2)、フロン等の単独物、又は2種以上の混合物(例えば空気)が挙げられる。前記噴射剤としては、汎用性が高いという点で液化ガスが好ましい。 As the propellant, liquefied gas (LPG) containing propane and butane is usually used. In addition, dimethyl ether, carbon dioxide, nitrogen (N 2 ), argon, oxygen (O 2 ), chlorofluorocarbon and the like alone or a mixture of two or more kinds (for example, air) can be used. As the propellant, a liquefied gas is preferable in terms of high versatility.
前記噴射剤の配合量は、特に限定されないが、本実施形態の後発泡性エアゾール組成物に40〜60重量%含有されていることが好ましい。 Although the compounding quantity of the said propellant is not specifically limited, It is preferable that 40-60 weight% is contained in the post-foamable aerosol composition of this embodiment.
なお、前記噴射剤は、本実施形態の後発泡性エアゾール組成物においては、前記非イオン性界面活性剤によって均一に分散され得る。従って、前記非イオン性界面活性剤、前記噴射剤、及び前記セルロースの微粒子が均一に分散され得るため、本実施形態の後発泡性エアゾール組成物は、上述したように、噴射された後の前記噴射剤の膨張に伴って、前記非イオン性界面活性剤及び前記セルロースの微粒子が密接に関わりながら作用し、後発泡性を示し、泡もちが良好となる。 The propellant can be uniformly dispersed by the nonionic surfactant in the post-foaming aerosol composition of the present embodiment. Therefore, since the nonionic surfactant, the propellant, and the cellulose fine particles can be uniformly dispersed, the post-foaming aerosol composition of the present embodiment, as described above, is Along with the expansion of the propellant, the nonionic surfactant and the cellulose fine particles act while being closely related to each other, exhibiting post-foaming properties and good foaming.
本実施形態の後発泡性エアゾール組成物は、前記セルロースの微粒子を分散させる液状分散媒体を含み得る。前記液状分散媒としては、通常、水が挙げられる。また、水溶性有機溶媒を含んだものが挙げられる。
前記水溶性有機溶媒としては、例えば、メタノール、エタノール、n−プロピルアルコール、iso−プロピルアルコール、n−ブチルアルコール、sec−ブチルアルコール、tert−ブチルアルコール等の炭素数1−4のアルキルアルコール類、ジメチルホルムアミド、ジメチルアセトアミド、アセトン、ジアセトンアルコール等のケトンまたはケトアルコール類、テトラヒドロフラン、ジオキサン等のエーテル類、カルビトール類等を挙げることができるが、これらに限定されるものではない。
The post-foaming aerosol composition of this embodiment may include a liquid dispersion medium in which the cellulose fine particles are dispersed. As the liquid dispersion medium, water is usually used. Moreover, what contains the water-soluble organic solvent is mentioned.
Examples of the water-soluble organic solvent include alkyl alcohols having 1 to 4 carbon atoms such as methanol, ethanol, n-propyl alcohol, iso-propyl alcohol, n-butyl alcohol, sec-butyl alcohol, tert-butyl alcohol, and the like. Examples include, but are not limited to, ketones such as dimethylformamide, dimethylacetamide, acetone, diacetone alcohol or keto alcohols, ethers such as tetrahydrofuran, dioxane, carbitols, and the like.
本実施形態の後発泡性エアゾール組成物は、本発明の効果を損わない範囲内において、添加物として、金属酸化物、金属、無機塩、シリカ系化合物などの無機化合物を含み得る。また、添加物として、オイル類、ガム類、ラテックス類、水溶性高分子類などの有機化合物を含み得る。その他、具体的な用途で分類される化粧品用途における有効成分、保湿剤、紫外線遮蔽剤、抗菌防腐剤など、又は医薬品用途における医薬、又は殺虫防虫用途における殺虫防虫剤、又は家庭用品用途における脱臭剤、その他、香料、染料、顔料等を含み得る。 The post-foaming aerosol composition of the present embodiment may contain an inorganic compound such as a metal oxide, a metal, an inorganic salt, or a silica-based compound as an additive within a range that does not impair the effects of the present invention. Moreover, organic compounds, such as oils, gums, latexes, and water-soluble polymers, can be included as an additive. In addition, active ingredients in cosmetic applications classified by specific use, moisturizers, UV screening agents, antibacterial preservatives, etc., pharmaceuticals in pharmaceutical applications, insecticides in insecticide applications, or deodorants in household products In addition, a fragrance | flavor, dye, a pigment, etc. may be included.
以下に、本実施形態の後発泡性エアゾール組成物に配合可能な添加物を具体的に記載する。 Below, the additive which can be mix | blended with the post-foamable aerosol composition of this embodiment is described concretely.
前記金属酸化物としては、二酸化チタン、アルミナ、二酸化亜鉛、ベンガラ、黄酸化鉄、黒酸化鉄等が挙げられるがこれらに限定されない。前記金属酸化物としては、噴射性能を損なわないように10μm以下、好ましくは5μm以下の平均粒径をもつように微細化されたものが望ましい。 Examples of the metal oxide include, but are not limited to, titanium dioxide, alumina, zinc dioxide, bengara, yellow iron oxide, and black iron oxide. The metal oxide is desirably refined to have an average particle size of 10 μm or less, preferably 5 μm or less so as not to impair the jetting performance.
前記無機塩としては塩化ナトリウム、塩化カルシウム、塩化マグネシウム、硫酸アンモニウム、リン酸カルシウム等が挙げられ、前記後発泡性エアゾール組成物の分散媒体に可溶なものを任意に採用することができるが、これらは配合量によっては前記セルロースの微粒子を強く凝集させる性質をもっているため、その配合量は、噴射性能に悪影響を及ぼさない程度に調節され得る。 Examples of the inorganic salt include sodium chloride, calcium chloride, magnesium chloride, ammonium sulfate, calcium phosphate, and the like, and those that are soluble in the dispersion medium of the post-foaming aerosol composition can be arbitrarily employed. Depending on the amount, it has the property of strongly agglomerating the cellulose fine particles, so that the blending amount can be adjusted to such an extent that it does not adversely affect the jetting performance.
前記金属としては、金、銀、銅、アルミニウム、マグネシウム、亜鉛、鉄等の金属から自由に選ぶことができ、その形状としては、噴射性能を損なわないように10μm以下、好ましくは5μm以下の平均粒径をもつ微粒子状であることが望ましい。 The metal can be freely selected from metals such as gold, silver, copper, aluminum, magnesium, zinc, and iron, and the shape thereof is an average of 10 μm or less, preferably 5 μm or less so as not to impair the jetting performance. It is desirable that the particles have a particle size.
前記シリカ系化合物としては、ゼオライト、モンモリロナイト、アスベスト、スメクタイト、マイカ、ヒュームドシリカ、コロイダルシリカ等が挙げられるが、これらに限定はされない。その形状としては、噴射性能を損なわないように10μm以下、好ましくは5μm以下の平均粒径をもつように微細化された微粒子状であるものが望ましい。 Examples of the silica compound include, but are not limited to, zeolite, montmorillonite, asbestos, smectite, mica, fumed silica, colloidal silica, and the like. The shape of the fine particles is desirably finely divided so as to have an average particle diameter of 10 μm or less, preferably 5 μm or less so as not to impair the jetting performance.
前記オイル類としては、ホホバ油、マカデミアナッツ油、アボガド油、月見草油、ミンク油、ナタネ油、ヒマシ油、ヒマワリ油、トウモロコシ油、カカオ油、ヤシ油、コメヌカ油、オリーブ油、アーモンド油、ゴマ油、サフラワー油、大豆油、椿油、パーシック油、ヒマシ油、ミンク油、綿実油、モクロウ、パーム油、パーム核油、卵黄油、ラノリン、スクワレン等の天然動植物油脂類;合成トリグリセライド、スクワラン、流動パラフィン、ワセリン、セレシン、マイクロクリスタリンワックス、イソパラフィン 等の炭化水素類;カルナバウロウ、パラフィンワック ス、鯨ロウ、ミツロウ、キヤンデリラワックス、ラノリン等のワックス類;セタノール、ステアリルアルコール、ラウリルアルコール、セトステアリルアルコール、オレイルアルコール、ベヘニルアルコール、ラノリンアルコール、水添ラノリンアルコール、ヘキシルデカノール、オクチルドデカノール等の高級アルコール類、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、イソステアリン酸、オレイン酸、リノレン酸、リノール酸、オキシステアリン酸、ウンデシレン酸、ラノリン脂肪酸、硬質ラノリン脂肪酸、軟質ラノリン脂肪酸等の高級脂肪酸類;コレステリル−オクチルドデシル−ベヘニル等のコレステロールおよびその誘導体;イソプロピルミリスチン酸、イソプロピルパルミチン酸、イソプロピルステアリン酸、2−エチルヘキサン酸グリセロール、ブチルステアリン酸等のエステル類;ジエチレングリコールモノプロピルエーテル、ポリオキシエチレンポリオキシプロピレンペンタエリトリトールエーテル、ポリオキシプロピレンブチルエーテル、リノール酸エチル等の極性オイル;その他アミノ変性シリコーン、エポキシ変性シリコーン、カルボキシル変性シリコーン、カルビノール変性シリコーン、メタクリル変性シリコーン、メルカプト変性シリコーン、フェノール変性シリコーン、片末端反応性シリコーン、異種官能基変性シリコーン、ポリエーテル変性シリコーン、メチルスチリル変性シリコーン、アルキル変性シリコーン、高級脂肪酸エステル変性シリコーン、親水性特殊変性シリコーン、高級アルコキシ変性シリコーン、高級脂肪酸含有シリコーン、フッ素変性シリコーン等、より具体的にはシリコン樹脂、メチルフェニルポリシロキサン、メチルポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン、メチルシクロポリシロキサン、オクタメチルトリシロキサン、デカメチルテトラシロキサン、ポリオキシエチレン・メチルポリシロキサン共重合体、ポリオキシプロピレン・メチルポリシロキサン共重合体、ポリ(オキシエチレン・オキシプロピレン)メチルポリシロキサン共重合体、メチルハイドロジェンポリシロキサン、テトラヒドロテトラメチルシクロテトラシロキサン、ステアロキシメチルポリシロキサン、セトキシメチルポリシロキサン、メチルポリシロキサンエマルション、高重合メチルポリシロキサン、トリメチルシロキシケイ酸、架橋型メチルポリシロキサン、架橋型メチルフェニルポリシロキサン、架橋型メチルフェニルポリシロキサン等の各種誘導体を含むシリコーン類等を挙げることができるが、これらに限定されるものではない。 Examples of the oils include jojoba oil, macadamia nut oil, avocado oil, evening primrose oil, mink oil, rapeseed oil, castor oil, sunflower oil, corn oil, cacao oil, palm oil, rice bran oil, olive oil, almond oil, sesame oil, safflower oil. Natural oils and fats such as flower oil, soybean oil, cocoon oil, persic oil, castor oil, mink oil, cottonseed oil, owl, palm oil, palm kernel oil, egg yolk oil, lanolin, squalene; synthetic triglyceride, squalane, liquid paraffin, petroleum jelly , Ceresin, microcrystalline wax, isoparaffin and other hydrocarbons; carnauba wax, paraffin wax, whale wax, beeswax, chiyandelilla wax, lanolin, etc .; cetanol, stearyl alcohol, lauryl alcohol, cetostearyl alcohol, olei Higher alcohols such as alcohol, behenyl alcohol, lanolin alcohol, hydrogenated lanolin alcohol, hexyl decanol, octyldodecanol, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, isostearic acid, oleic acid, linolenic acid, linoleic acid, Higher fatty acids such as oxystearic acid, undecylenic acid, lanolin fatty acid, hard lanolin fatty acid, soft lanolin fatty acid; cholesterol and derivatives thereof such as cholesteryl-octyldodecyl-behenyl; isopropyl myristic acid, isopropyl palmitic acid, isopropyl stearic acid, 2- Esters such as glycerol ethylhexanoate and butylstearic acid; diethylene glycol monopropyl ether, polyoxyethylene polyoxypropylene Polar oils such as N-pentaerythritol ether, polyoxypropylene butyl ether, ethyl linoleate; other amino-modified silicone, epoxy-modified silicone, carboxyl-modified silicone, carbinol-modified silicone, methacryl-modified silicone, mercapto-modified silicone, phenol-modified silicone, one end Reactive silicones, heterogeneous functional group-modified silicones, polyether-modified silicones, methylstyryl-modified silicones, alkyl-modified silicones, higher fatty acid ester-modified silicones, hydrophilic specially modified silicones, higher alkoxy-modified silicones, higher fatty acid-containing silicones, fluorine-modified silicones, etc. More specifically, silicone resin, methylphenylpolysiloxane, methylpolysiloxane, octamethylcyclotetrasilo Sun, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane, methylcyclopolysiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, polyoxyethylene / methylpolysiloxane copolymer, polyoxypropylene / methylpolysiloxane copolymer, Poly (oxyethylene oxypropylene) methyl polysiloxane copolymer, methyl hydrogen polysiloxane, tetrahydrotetramethylcyclotetrasiloxane, stearoxymethyl polysiloxane, cetoxymethyl polysiloxane, methyl polysiloxane emulsion, highly polymerized methyl polysiloxane , Trimethylsiloxysilicic acid, crosslinked methylpolysiloxane, crosslinked methylphenylpolysiloxane, crosslinked methylphenylpolysiloxane It can be cited silicones such as including various derivatives of emissions such as, but not limited thereto.
前記ガム類としては、アラビアガム、キサンタンガム、グアーガム、ローカストビンガム、クインスシード、カラギーナン等を挙げることができるが、これらに限定されるものではない。 Examples of the gums include, but are not limited to, gum arabic, xanthan gum, guar gum, locust bin gum, quince seed, and carrageenan.
前記ラテックス類としては、スチレン−ブタジエン共重合系ラテックス、アクリル系ラテックス等を挙げることができるが、乳化重合によって得られる高分子ラテックスであればこれらに限定されるものではない。 Examples of the latex include styrene-butadiene copolymer latex and acrylic latex, but are not limited to these as long as it is a polymer latex obtained by emulsion polymerization.
前記水溶性高分子類としては、ポリエチレングリコール、ポリビニルアルコール、カチオン化セルロース、カルボキシビニルポリマー、ポリビニルピロリドン、ポリビニルピロリドン/酢酸ビニル共重合体、ポリアクリル酸、ポリアクリルアミド、アルギン酸、ポリデキストロース、カルボキシメチルセルロース、ヒドロキシエチルセルロース等を挙げることができるが、これらに限定されるものではない。 Examples of the water-soluble polymers include polyethylene glycol, polyvinyl alcohol, cationized cellulose, carboxyvinyl polymer, polyvinylpyrrolidone, polyvinylpyrrolidone / vinyl acetate copolymer, polyacrylic acid, polyacrylamide, alginic acid, polydextrose, carboxymethylcellulose, Although hydroxyethyl cellulose etc. can be mentioned, it is not limited to these.
化粧品用途における前記有効成分としては、アルブチン、コウジ酸、リン酸アスコルビン酸マグネシウムなどのアスコルビン酸およびその誘導体、グルタチオン、甘草エキス、チョウジエキス、茶抽出物、アスタキサンチン、牛胎盤エキス、トコフェロールおよびその誘導体、トラネキサム酸およびその塩、アズレン、γ−ヒドロキシ酪酸等の美白成分、クエン酸、リンゴ酸、酒石酸、乳酸、アジピン酸、グルタミン酸、アスパラギン酸、マレイン酸等の有機酸、ビタミンB6塩酸塩、ビタミン6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2及びその誘導体等のビタミンB類、アスコルビン酸、アスコルビン酸硫酸エステル、アスコルビン酸リン酸エステル等のビタミンC類、αトコフェロール、βトコフェロール、γトコフェロール等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸等のビタミン類;ニコチン酸アミド、ニコチン酸ベンジル、γ−オリザノール、アラントイン、グリチルリチン酸(塩)グリチルレチン酸およびその誘導体、ヒノキチオール、ムシジン、ビサボロール、ユーカリプトール、チモールイノシトール、サポニン類(キラヤサポニン、アズキサポニン、ヘチマサポニン等)トラネキサム酸、パントテルエチルエーテル、エチニルエストラ ジオール、セファランジン、プラセンタエキス、センブリエキス、セファランチン、ビタミンEおよびその誘導体、ガンマーオリザノールなどの血行促進剤、トウガラシチンキ、ショオウキョウチンキ、カンタリスチンキ、ニコチン酸ベンジルエステルなどの局所刺激剤;グリチルレチン酸、グリチルリチン酸誘 導体、塩化カルプロニウム、ノニル酸ワニリルアミド、アラントイン、アズレン、アミノカプロン酸、ヒドロコルチゾンなどの抗炎症剤、酸化亜鉛、硫酸亜鉛、アラントインヒドロキシアルミニウム、塩化アルミニウム、スルホ石炭酸亜鉛、タンニン酸などの収斂剤、メントール、カンフルなどの清涼剤、抗ヒスタミン剤、高分子シ リコーン、環状シリコーン等のシリコン系物質、トコフェロール類、没食子酸などの酸化防止剤等の各種薬剤;サッカロマイセスなどの酵母、糸状菌、バクテリア、牛胎盤、人胎盤、人臍帯、小麦、大豆、牛血液、ブタ血液、鶏冠、カミツレ、キュウリ、コメ、シアバター、シラカバ、茶、トマト、ニンニク、ハマメリス、バラ、ヘチマ、ホップ、モモ、アンズ、レモン、キウイ、ドクダミ、トウガラシ、クララ、ギシギシ、コウホネ、セージ、ノコギリ草、ゼニアオイ、センキュウ、センブリ、タイム、トウキ、トウヒ、バーチ、スギナ、マロニエ、ユキノシタ、アルニカ、ユリ、ヨモギ、シャクヤク、アロエ、アロエベラ、オウゴン、オウバク、コウカ、ベニバナ、サンシン、シコン、タイソウ、チンピ、ニンジン、ヨクイニン、ハトムギ、クチナシ、サワラ等の動植物・微生物およびその一部から有機溶媒、アルコール、多価アルコール、水、水性アルコール等で抽出または加水分解して得た天然エキス等を挙げることができるが、これらに限定されるものではない。 As the active ingredient in cosmetic use, ascorbic acid and derivatives thereof such as arbutin, kojic acid, magnesium ascorbate phosphate, glutathione, licorice extract, clove extract, tea extract, astaxanthin, cow placenta extract, tocopherol and derivatives thereof, Whitening ingredients such as tranexamic acid and its salts, azulene, γ-hydroxybutyric acid, citric acid, malic acid, tartaric acid, lactic acid, adipic acid, glutamic acid, aspartic acid, maleic acid and other organic acids, vitamin B6 hydrochloride, vitamin 6 tri Vitamin B such as palmitate, vitamin B6 dioctanoate, vitamin B2 and derivatives thereof, vitamin C such as ascorbic acid, ascorbic acid sulfate, ascorbic acid phosphate, α-tocopherol, β-tocopherol, γ-to Vitamin E such as ferrol, vitamin D such as vitamin D, vitamin H, pantothenic acid, etc .; nicotinamide, benzyl nicotinate, γ-oryzanol, allantoin, glycyrrhizic acid (salt) glycyrrhetinic acid and its derivatives, hinokitiol, mucidin, Bisabolol, eucalyptol, thymol inositol, saponins (Quillaja saponin, azoxaponin, hechisaponin, etc.) tranexamic acid, pantotel ethyl ether, ethinyl estradiol, cephalanthin, placenta extract, assembly extract, cephalanthin, vitamin E and its derivatives, Circulatory agents such as gamma-oryzanol, local stimulants such as chili pepper tincture, ginger tincture, cantalis tincture, nicotinic acid benzyl ester; glycyrrhetin Acids, glycyrrhizic acid derivatives, carpronium chloride, nonyl acid vanillylamide, allantoin, azulene, aminocaproic acid, hydrocortisone and other anti-inflammatory agents, zinc oxide, zinc sulfate, allantoin hydroxyaluminum, aluminum chloride, sulfosulfonate zinc, tannic acid, etc. Agents, menthols and other refreshing agents, antihistamines, high molecular silicones, silicones such as cyclic silicones, various agents such as antioxidants such as tocopherols and gallic acid; yeasts such as Saccharomyces, filamentous fungi, bacteria, Cow placenta, human placenta, human umbilical cord, wheat, soybeans, cow blood, pig blood, chicken crown, chamomile, cucumber, rice, shea butter, birch, tea, tomato, garlic, hamamelis, rose, loofah, hop, peach, apricot, Lemon, kiwi, de Dami, capsicum, clara, scallop, corn, sage, sawtooth grass, mallow, nematode, assembly, thyme, spruce, spruce, birch, horsetail, maroonier, yukinoshita, arnica, lily, mugwort, peonies, aloe, aloe vera, dragon Extracted or hydrated with organic solvents, alcohol, polyhydric alcohols, water, aqueous alcohol, etc. from animals, plants, microorganisms and parts thereof such as sorghum Examples include natural extracts obtained by decomposition, but are not limited thereto.
化粧品用途における前記保湿剤としては、マルチトール、ソルビトール、グリセリン、プロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール、グリコール等の多価アルコール、ピロリドンカルボン酸ソーダ、乳酸ソーダ、クエン酸ソーダなど有機酸およびその塩、ヒアルロン酸ソーダなどヒアルロン酸およびその塩、酵母および酵母抽出液の加水分解物、酵母培養液、乳酸菌培養液など醗酵代謝産物、コラーゲン、エラスチン、ケラチン、セリシン等の水溶性蛋白、コラーゲン加水分解物、カゼイン加水分解物、シルク加水分解物、ポリアスパラギン酸ナトリウム等のぺプチド類およびその塩、トレハロース、キシロビオース、マルトース、蔗糖、ブドウ糖、植物性粘質多糖等の糖類・多糖類およびその誘導体、水溶性キチン、キトサン、ペクチン、コンドロイチン硫酸およびその塩等のグリコサミノグリカンおよびその塩、グリシン、セリン、スレオニン、アラニン、アスパラギン酸、チロシン、バリン、ロイシン、アルギニン、グルタミン、プロリン酸等のアミノ酸、アミノカルボニル反応物等の糖アミノ酸化合物、アロエ、マロニエ等の植物抽出液、トリメチルグリシン、尿素、尿酸、アンモニア、レシチン、ラノリン、スクワラン、スクワレン、グルコサミン、クレアチニン、DNA、RNA等の核酸関連物質等を挙げることができるが、これらに限定されるものではない。アミノ酸としては、グルタミン酸、アスパラギン酸、グリシン、リジンなどの公知のアミノ酸が採用され得る。 Examples of the moisturizing agent for cosmetic use include polyhydric alcohols such as maltitol, sorbitol, glycerin, propylene glycol, 1,3-butylene glycol, polyethylene glycol, and glycol, organic acids such as pyrrolidone carboxylate, sodium lactate, and sodium citrate. And salts thereof, hyaluronic acid and its salts such as sodium hyaluronate, hydrolyzate of yeast and yeast extract, fermentation metabolites such as yeast culture and lactic acid bacteria culture, water-soluble proteins such as collagen, elastin, keratin, and sericin, collagen Hydrolysates, casein hydrolysates, silk hydrolysates, peptides such as sodium polyaspartate and their salts, saccharides / polysaccharides such as trehalose, xylobiose, maltose, sucrose, glucose, vegetable viscous polysaccharides and the like Derivative, water Glycosaminoglycans and their salts such as sex chitin, chitosan, pectin, chondroitin sulfate and their salts, amino acids such as glycine, serine, threonine, alanine, aspartic acid, tyrosine, valine, leucine, arginine, glutamine and prophosphoric acid, amino Examples include sugar amino acid compounds such as carbonyl reactants, plant extracts such as aloe and maronier, trimethylglycine, urea, uric acid, ammonia, lecithin, lanolin, squalane, squalene, glucosamine, creatinine, DNA, RNA, etc. However, it is not limited to these. As the amino acid, known amino acids such as glutamic acid, aspartic acid, glycine and lysine can be adopted.
化粧品用途における前記紫外線遮蔽剤としては、パラアミノ安息香酸およびその誘導体、ホモメチル−7N−アセチルアラントイラニレート、ブチルメトキシベンゾイルメタン、ジ−パラメトキシケイ皮酸−モノ−2−エチルヘキサン酸グリセリル、オクチルシンナメート等のパラメトキシケイ皮酸誘導体、アミルサリシレート等のサリチル酸誘導体、2,4−ジヒドロキシベンゾフェノン等のベンゾフェノン誘導体、ジメトキシベンジリデンジオキソイミダゾリンプロピオン酸エチルヘキシル、酢酸液状ラノリン、コガネバナ根抽出エキス、トリアニリノ−p−カルボエチルヘキシルオキシートリアジン等が挙げられるが、これらに限定されるものではない。 Examples of the ultraviolet screening agent for cosmetic use include paraaminobenzoic acid and its derivatives, homomethyl-7N-acetylaranthranilate, butylmethoxybenzoylmethane, di-paramethoxycinnamic acid-mono-2-ethylhexanoic acid glyceryl, octyl Paramethoxycinnamic acid derivatives such as cinnamate, salicylic acid derivatives such as amyl salicylate, benzophenone derivatives such as 2,4-dihydroxybenzophenone, ethyl hexyl dimethoxybenzylidene dioxoimidazoline propionate, liquid lanolin acetate extract, trianilino-p -Carboethylhexyloxy-triazine etc. are mentioned, However, It is not limited to these.
化粧品用途における前記抗菌防腐剤としては、安息香酸およびその塩、サリチル酸およびその塩、ソルビン酸およびその塩、パラオキシ安息香酸アルキルエステル(エチルパラベン、ブチルパラベン等)およびその塩、デヒドロ酢酸およびその塩類、パラクロルメタクレゾール、ヘキサクロロフェン、ホウ酸、レゾルシン、トリブロムサラン、オルトフェニルフェノール、グルコン酸クロルヘキシジン、チラム、感光素201号、フェノキシエタノール、塩化ベンザルコニウム、塩化ベンゼトニウム、ハロカルバン、塩化クロルヘキシジン、トリクロロカルバニド、酢酸トコフェロール、ジンクピリチオン、ヒノキチオール、フェノール、イソプロピルメチルフェノール、2,4,4−トリクロロ−2−ヒドロキシフェノール、ヘキサクロロフェン等が挙げられるが、これらに限定されるものではない。これらは、医薬品用途でも用いられ得る。 Examples of the antibacterial preservative for cosmetic use include benzoic acid and its salts, salicylic acid and its salts, sorbic acid and its salts, paraoxybenzoic acid alkyl esters (ethyl paraben, butyl paraben, etc.) and their salts, dehydroacetic acid and its salts, Parachlormetacresol, hexachlorophene, boric acid, resorcin, tribromosaran, orthophenylphenol, chlorhexidine gluconate, thiram, photosensitizer 201, phenoxyethanol, benzalkonium chloride, benzethonium chloride, halocarban, chlorhexidine chloride, trichlorocarba Nido, tocopherol acetate, zinc pyrithione, hinokitiol, phenol, isopropylmethylphenol, 2,4,4-trichloro-2-hydroxyphenol, hexachloro E down like although not limited thereto. They can also be used in pharmaceutical applications.
医薬品用途における前記医薬としては、漢方医薬品を含むすべての薬効のある薬剤を挙げることができるが、薬剤の薬効は共存する化合物によって大きく変動し得るため、組成物の配合においては、通常、適宜適切な処方を組む。 Examples of the pharmaceutical in pharmaceutical use include all drugs having a medicinal effect, including Kampo medicines, but the drug efficacy can vary greatly depending on the coexisting compounds, and therefore it is usually appropriate as appropriate in the formulation of the composition. Make a proper prescription.
殺虫防虫用途における前記殺虫防虫剤としては、代表的なものとして、ショウノウ、ナフタリン、パラジクロルベンゼン、パラフォーム、クロルピクリン、除虫菊、スルホンベンズアルデヒド類、フェニルメタン系化合物等を挙げることができるが、これらに限定されるものではない。 Representative examples of the insecticide for insecticide use include camphor, naphthalene, paradichlorobenzene, paraform, chloropicrin, insecticide, sulfonbenzaldehydes, phenylmethane compounds, and the like. It is not limited.
家庭用品用途における前記脱臭剤としては、活性炭をはじめとする固体および溶解性の脱臭効果を有する化合物を挙げることができるが、固体成分を配合する場合には、噴射特性を損なわないように10μm以下、好ましくは5μm以下の平均粒径をもつように微細化されたものが望ましい。 Examples of the deodorizer for household products include solid and soluble deodorizing compounds such as activated carbon. When a solid component is blended, 10 μm or less so as not to impair the injection characteristics. It is desirable that the material is refined to have an average particle size of 5 μm or less.
前記香料としては、公知のすべての香料原料が挙げられ得るが、組成物の配合成分の中で匂いを打ち消す効果が少ないような処方を選定することが望ましい。 As the fragrance, all known fragrance raw materials may be mentioned, but it is desirable to select a prescription that has less effect of canceling the odor among the ingredients of the composition.
前記染料、前記顔料としては、繊維染色、各種印刷、コピー、筆記具等の分野で一般的に使用される染料や顔料の任意のものが用いられ得る。なお、着色能を有する色材であればこれらに限定されるものではない。 As the dye and the pigment, any of dyes and pigments generally used in the fields of fiber dyeing, various printing, copying, writing instruments and the like can be used. In addition, if it is a coloring material which has coloring ability, it will not be limited to these.
次に、本実施形態の後発泡性エアゾール組成物の製造方法について説明する。本実施形態の後発泡性エアゾール組成物は、例えば、次のようにして製造することができる。 Next, the manufacturing method of the post-foaming aerosol composition of this embodiment is demonstrated. The post-foaming aerosol composition of the present embodiment can be produced, for example, as follows.
前記セルロースの微粒子は、例えば、セルロースを溶解させ得る溶媒にセルロースを主成分とする原料を一旦溶解させ、セルロースが溶解しているこの溶液を、セルロースが溶解しない溶媒に投入してセルロース凝集させ、続いて凝集したこのセルロースを粉砕処理することにより調製できる。 For example, the cellulose fine particles may be prepared by once dissolving a raw material mainly composed of cellulose in a solvent capable of dissolving cellulose, and adding the solution in which cellulose is dissolved into a solvent in which cellulose is not dissolved to aggregate the cellulose. Subsequently, the agglomerated cellulose can be prepared by pulverizing.
前記セルロースを溶解させ得る溶媒としては、例えば、硫酸、ジメチルアセトアミド、銅エチレンジアミン等が挙げられる。中でも、後の除去作業の簡便さ、残留分の人体への影響の少なさの観点から、硫酸が好ましい。 Examples of the solvent capable of dissolving the cellulose include sulfuric acid, dimethylacetamide, copper ethylenediamine, and the like. Among these, sulfuric acid is preferable from the viewpoint of ease of subsequent removal work and little influence on the human body of the remaining portion.
前記セルロースを凝集させる方法としては、水等の溶媒中にセルロース溶液を投入してセルロースを得る再沈殿が挙げられる。セルロースを再沈殿させる溶媒としては、水や50重量%以下の濃度の水溶性アルコール水溶液等が挙げられる。中でも、後の除去作業の簡便さ、残留分の皮膚への悪影響の観点から、水が好ましい。なお、再沈殿されたセルロースは、通常、複数回洗浄される。 Examples of the method for aggregating the cellulose include reprecipitation in which a cellulose solution is poured into a solvent such as water to obtain cellulose. Examples of the solvent for reprecipitation of cellulose include water and a water-soluble alcohol aqueous solution having a concentration of 50% by weight or less. Among these, water is preferable from the viewpoint of ease of subsequent removal work and adverse effects on the remaining portion of the skin. The reprecipitated cellulose is usually washed a plurality of times.
再沈殿されたセルロースの粉砕処理としては、ビーズミル、ニーダー、ディスパー、ホモジナイザー、超高圧ホモジナイザー等による粉砕処理が挙げられる。この粉砕処理は、粉砕効率の観点から、ホモジナイザー等で予備分散後、さらに超高圧ホモジナイザーによる粉砕処理が好ましい。 Examples of the pulverization treatment of the reprecipitated cellulose include a pulverization treatment using a bead mill, a kneader, a disper, a homogenizer, an ultrahigh pressure homogenizer, and the like. From the viewpoint of pulverization efficiency, this pulverization is preferably performed after preliminary dispersion with a homogenizer or the like, and further with an ultrahigh pressure homogenizer.
続いて、本実施形態のエアゾール製品について説明する。本実施形態のエアゾール製品は、上述した後発泡性エアゾール組成物がエアゾール容器に充填されているものである。 Then, the aerosol product of this embodiment is demonstrated. The aerosol product of the present embodiment is an aerosol container filled with the above-described post-foaming aerosol composition.
前記エアゾール製品は、通常、ボタンを押すことでバルブが開き、容器内で圧力をかけられている前記後発泡性エアゾール組成物がディップチューブを通ってボタンの孔から噴射されるものである。噴射された前記後発泡性エアゾール組成物は、上述したように、噴射された直後は発泡せず、噴射されてしばらく経ってから噴射剤の膨張によって発泡する。
詳しくは、前記後発泡性エアゾール組成物がチクソトロピー性を有するため、前記エアゾール容器を傾ける等による比較的低いずり応力では前記後発泡性エアゾール組成物が流動しないものの、噴射時におけるエアゾール容器内の圧力と外気圧との差圧に起因する比較的高いずり応力で前記後発泡性エアゾール組成物が低粘度化し、ディップチューブを通って前記後発泡性エアゾール組成物が噴射されることとなる。
The aerosol product is usually one in which a valve is opened by pressing a button, and the post-foaming aerosol composition being pressurized in the container is sprayed from a button hole through a dip tube. As described above, the sprayed post-foaming aerosol composition does not foam immediately after being sprayed, and foams due to expansion of the propellant after a while after being sprayed.
Specifically, since the post-foaming aerosol composition has thixotropic properties, the post-foaming aerosol composition does not flow at a relatively low shear stress caused by tilting the aerosol container, but the pressure in the aerosol container at the time of injection The post-foaming aerosol composition is lowered in viscosity by a relatively high shear stress resulting from the differential pressure between the pressure and the external pressure, and the post-foaming aerosol composition is injected through the dip tube.
なお、前記エアゾール容器は、通常、キャップ、ボタン、バルブ、ディップチューブ、耐圧容器(エアゾール缶等)などで構成されている。 The aerosol container is usually composed of a cap, a button, a valve, a dip tube, a pressure resistant container (such as an aerosol can), and the like.
前記エアゾール製品は、上記の実施形態の後発泡性エアゾール組成物を従来公知の一般的な方法によって、前記エアゾール容器に充填することにより製造することができる。 The aerosol product can be produced by filling the aerosol container with the post-foaming aerosol composition of the above-described embodiment by a conventionally known general method.
本発明は、上記例示の後発泡性エアゾール組成物及びエアゾール製品に限定されるものではない。
また、一般の後発泡性エアゾール組成物及びエアゾール製品において用いられる種々の態様を、本発明の効果を損ねない範囲において、採用することができる。
The present invention is not limited to the above-described exemplary post-foaming aerosol compositions and aerosol products.
Moreover, the various aspects used in a general post-foaming aerosol composition and aerosol product can be employed as long as the effects of the present invention are not impaired.
以下、実施例を挙げて本発明についてさらに詳細に説明する。 Hereinafter, the present invention will be described in more detail with reference to examples.
<セルロースの微粒子の調製>
(1)セルロースの微粒子の分散体の調製
シート状の精製パルプを5mm×5mmのチップに切断した重合度760の原料パルプ(以下、単に精製パルプという)を、−5℃でセルロース濃度が5重量%になるように65重量% 硫酸水溶液に溶解して、透明かつ粘調なセルロースドープを得た。このセルロースドープを、重量で2.5倍量の水中(5℃)に撹拌しながら注ぎ、セルロースをフロック状に凝集させ、フロック状固体の分散液を得た。この懸濁液を、85℃で20分間の条件で加水分解処理し、ガラスフィルターを用いた減圧ろ過により分散媒である硫酸水溶液を除去し、ついで洗液のpHが3程度になるまで十分に水洗と脱水とを繰り返した後、pHが約11のアンモニア水溶液で洗浄(中和)した後、さらにイオン交換水で水洗し、セルロース濃度が6.0重量%の半透明白色のゲル状物を得た。
得られたゲル状物に、セルロース濃度が4重量%となるようにイオン交換水を添加し、ホモミキサー(特殊機化社製、機種名:TKロボミックス)を用いて15000rpmの回転速度で10分間分散処理を行い、引き続いて、超高圧ホモジナイザー(みづほ工業社製、機種名:マイクロフルイダイザーM−110−E/H)を用いて1.72×108Paの圧力下で5回処理し、透明性の高いセルロース微粒子の水分散体(pH=6.7)を得た。このセルロース微粒子の水分散体を試料A(セルロース固形分4重量%)とする。
<Preparation of cellulose fine particles>
(1) Preparation of Cellulose Fine Particle Dispersion Raw material pulp having a polymerization degree of 760 (hereinafter simply referred to as purified pulp) obtained by cutting sheet-like refined pulp into 5 mm × 5 mm chips, and having a cellulose concentration of 5 wt. % And dissolved in a 65 wt% sulfuric acid aqueous solution to obtain a transparent and viscous cellulose dope. This cellulose dope was poured into 2.5 times by weight of water (5 ° C.) with stirring, and the cellulose was aggregated in a floc form to obtain a dispersion of a floc solid. This suspension is hydrolyzed at 85 ° C. for 20 minutes, and the sulfuric acid aqueous solution, which is a dispersion medium, is removed by vacuum filtration using a glass filter. After repeating washing with water and dehydration, washing (neutralization) with an aqueous ammonia solution having a pH of about 11, followed by washing with ion-exchanged water, a translucent white gel with a cellulose concentration of 6.0% by weight was obtained. Obtained.
Ion-exchanged water was added to the obtained gel-like material so that the cellulose concentration was 4% by weight, and the rotation speed was 15000 rpm using a homomixer (model name: TK Robotics) manufactured by Homomixer. Dispersion treatment is performed for 5 minutes, and subsequently, the treatment is performed 5 times under a pressure of 1.72 × 108 Pa using an ultra-high pressure homogenizer (manufactured by Mizuho Kogyo Co., Ltd., model name: Microfluidizer M-110-E / H), and transparent. A highly water-soluble dispersion of cellulose fine particles (pH = 6.7) was obtained. This aqueous dispersion of cellulose fine particles is designated as Sample A (cellulose solid content 4% by weight).
(2)セルロースの平均重合度の測定
前記(1)で得られたゲル状のセルロース微粒子の分散体を、70℃で乾燥させた。乾燥させたセルロース微粒子 200mg、400mg、600mg、800mgまたは1000mgを、カドキセン 50mlに溶解して得られた希薄セルロース溶液の25℃における比粘度をウベローデ型粘度計を用いて測定し、極限粘度数ηを、濃度0に外挿したときの比粘度として算出した。ついで、得られた極限粘度数ηに基づき、式(I):
η=3.85×10-2×Mw0.76 (I)
(式中、Mwは、重量平均分子量を示す)
と、式(II):
平均重合度=Mw/162 (II)
(式中、Mwは、重量平均分子量を示す)
とにより、平均重合度を算出した。
その結果、試料Aのセルロースの平均重合度は、40であった。
(2) Measurement of average degree of polymerization of cellulose The dispersion of gel-like cellulose fine particles obtained in (1) was dried at 70 ° C. The specific viscosity at 25 ° C. of a diluted cellulose solution obtained by dissolving 200 mg, 400 mg, 600 mg, 800 mg or 1000 mg of dried cellulose fine particles in 50 ml of cadoxene was measured using an Ubbelohde viscometer, and the intrinsic viscosity number η was determined. The specific viscosity when extrapolated to a concentration of 0 was calculated. Then, based on the obtained intrinsic viscosity number η, the formula (I):
η = 3.85 × 10 −2 × Mw 0.76 (I)
(Wherein, Mw represents the weight average molecular weight)
And formula (II):
Average degree of polymerization = Mw / 162 (II)
(Wherein, Mw represents the weight average molecular weight)
From these, the average degree of polymerization was calculated.
As a result, the average degree of polymerization of the cellulose of Sample A was 40.
(3)セルロースの結晶化率の測定
前記(1)で得られたゲル状のセルロース微粒子の分散体を、70℃で乾燥させた後、粉砕し、錠剤に成形して、線源CuKα、反射法での広角X線回折法(リガク社製、RINT−ULtimaIII)により得られた回折図において、セルロースI型結晶(110)面ピークに帰属される2θ=15.0°における絶対ピーク強度h0と、この面間隔におけるベースラインからのピーク強度h1から下記(III)式よりセルロースI型結晶成分の分率(χI)を求めた。同様に、前記回折図において、セルロースII型結晶(110)面ピークに帰属される2θ=12.6°における絶対ピーク強度h0 *と、この面間隔におけるベースラインからのピーク強度h1 *から下記(IV)式よりセルロースII型結晶成分の分率(χII)を求めた。
χI=h1/h0 (III)
χII=h1 */h0 * (IV)
そして、セルロースI型結晶成分の分率(χI)とセルロースII型結晶成分の分率(χII)とを用い、下記(V)式よりセルロースの結晶化率を求めた。
結晶化率(%)=(χI+χII)×100 (V)
その結果、試料Aのセルロースの結晶化率は、20(%)であった。
(3) Measurement of crystallization rate of cellulose The dispersion of gel-like cellulose fine particles obtained in the above (1) was dried at 70 ° C., pulverized, formed into a tablet, the source CuKα, reflection In the diffraction diagram obtained by the wide-angle X-ray diffraction method (RINT-ULtimaIII, manufactured by Rigaku Corporation), the absolute peak intensity h 0 at 2θ = 15.0 ° attributed to the cellulose I type crystal (110) plane peak. Then, the fraction (χ I ) of the cellulose I-type crystal component was determined from the peak intensity h 1 from the baseline at this interplanar spacing by the following formula (III). Similarly, in the diffractogram, from the absolute peak intensity h 0 * at 2θ = 12.6 ° attributed to the cellulose II type crystal (110) plane peak and the peak intensity h 1 * from the baseline at this plane spacing. The fraction (χ II ) of cellulose II type crystal component was determined from the following formula (IV).
χ I = h 1 / h 0 (III)
χ II = h 1 * / h 0 * (IV)
Then, using the fraction of cellulose I type crystal component (χ I ) and the fraction of cellulose II type crystal component (χ II ), the crystallization rate of cellulose was determined from the following formula (V).
Crystallization rate (%) = (χ I + χ II ) × 100 (V)
As a result, the crystallization rate of cellulose of Sample A was 20 (%).
(4)セルロース微粒子の平均粒子径の測定
前記(1)で得られたセルロース微粒子の分散体を、1.5重量%濃度となるように、水で希釈し、続いて超高圧ホモジナイザー(マイクロフルタイザーM−110−E/H、圧力:100MPa)により超高圧分散処理した。得られた分散液を、マイクロトラック粒度分布測定装置UPA(日機装社製)で平均粒子径を測定した。なお、平均粒子径としては、体積基準径における50%径である累積中位径(メジアン径)を採用した。
その結果、試料Aのセルロースの微粒子の平均粒子径は、20nmであった。
(4) Measurement of average particle diameter of cellulose fine particles The dispersion of cellulose fine particles obtained in the above (1) was diluted with water so as to have a concentration of 1.5% by weight, and then an ultra-high pressure homogenizer (microfluidic). Ultra-high pressure dispersion treatment was performed using Tizer M-110-E / H, pressure: 100 MPa. The average particle diameter of the obtained dispersion was measured with a Microtrac particle size distribution analyzer UPA (manufactured by Nikkiso Co., Ltd.). In addition, as an average particle diameter, the accumulation median diameter (median diameter) which is a 50% diameter in a volume reference | standard diameter was employ | adopted.
As a result, the average particle size of the cellulose fine particles of Sample A was 20 nm.
上記のセルロース微粒子の水分散体(試料A)を用いて、実施例1〜12、及び比較例1〜9の後発泡性エアゾール組成物及びエアゾール製品を製造した。各実施例、比較例における配合組成を表1に示す。 Using the above aqueous dispersion of cellulose fine particles (Sample A), post-foaming aerosol compositions and aerosol products of Examples 1 to 12 and Comparative Examples 1 to 9 were produced. Table 1 shows the composition of each example and comparative example.
(実施例1)
表1の配合組成に従い、試料Aと、非イオン界面活性剤としてのポリオキシエチレン硬化ヒマシ油(平均付加E.O. 60モル 第一工業製薬社製 商品名「ノイゲンHC−600」と、精製水とをホモミキサー(特殊機化社製、機種名:TKロボミックス)を用いて10,000rpmの回転速度で10分間撹拌したものをエアゾール容器(東京高分子社製 100mLエアゾール缶)に充填し、エアゾールバルブ装着の直前にLPGを充填し、エアゾール製品を製造した。
Example 1
According to the composition of Table 1, sample A and polyoxyethylene hydrogenated castor oil as non-ionic surfactant (average addition EO 60 mol, manufactured by Daiichi Kogyo Seiyaku Co., Ltd., trade name “Neugen HC-600” and purification A mixture of water and agitated for 10 minutes at a rotation speed of 10,000 rpm using a homomixer (made by Tokushu Kika Co., Ltd., model name: TK Robotics) is filled into an aerosol container (100 mL aerosol can made by Tokyo Polymer Co., Ltd.). The LPG was filled immediately before the aerosol valve was mounted to produce an aerosol product.
(実施例2〜8,13〜14)
表1に示す配合組成とした点以外は、実施例1と同様にして後発泡性エアゾール組成物及びエアゾール製品を製造した。
(Examples 2-8, 13-14)
A post-foaming aerosol composition and an aerosol product were produced in the same manner as in Example 1 except that the composition shown in Table 1 was used.
(実施例9〜12)
非イオン界面活性剤としてイソステアリン酸デカグリセリルを用いた点、その他、表1に示す配合組成とした点以外は、実施例1と同様にして後発泡性エアゾール組成物及びエアゾール製品を製造した。
(Examples 9 to 12)
A post-foaming aerosol composition and an aerosol product were produced in the same manner as in Example 1 except that decaglyceryl isostearate was used as the nonionic surfactant and the blending composition shown in Table 1 was used.
(比較例1〜9)
表1に示す配合組成とした点以外は、実施例1と同様にして後発泡性エアゾール組成物及びエアゾール製品を製造した。なお、キサンタンガム、ヒドロキシプロピルセルロースとしては、下記のものを用いた。
・キサンタンガム 商品名「エコーガム」 大日本住友製薬社製
・ヒドロキシプロピルセルロース 試薬 東京化成工業社製
(Comparative Examples 1-9)
A post-foaming aerosol composition and an aerosol product were produced in the same manner as in Example 1 except that the composition shown in Table 1 was used. In addition, the following were used as xanthan gum and hydroxypropyl cellulose.
・ Xanthan gum Brand name “Echo gum” manufactured by Dainippon Sumitomo Pharma Co., Ltd. ・ Hydroxypropyl cellulose reagent manufactured by Tokyo Chemical Industry
<噴射性能の評価>
製造したエアゾール製品を用いて、内容物を噴射させ、噴霧状態、液だれ性、起泡性、泡もち、上下反対向きでの噴射の可否について目視にて評価した。各評価項目は、最良(◎)、良(○)、やや悪(△)、悪(×)の4段階で評価した。
噴霧状態は、噴射時に細かい霧状となるものを最良(◎)、噴射できないものを悪(×)として評価した。
液だれ性は、次のようにして評価した。即ち、18cm×18cmの曇りガラス板を垂直に立て、水平距離で20cm離れた位置からガラス板に向けて1回噴射し、さらに噴射を数回行い、ガラス面において隙間のないようになるまで噴射を続け、ガラス面上での液だれ性を噴射ごとに観察し、複数回の噴射によっても全く液だれが起こらないものを最良(◎)、1回の噴射でも液だれが起こるものを悪(×)として評価した。
起泡性は、噴射1秒後の泡の量が多いものを最良(◎)、泡がたたないものを悪(×)として評価した。
泡もちは、噴射1秒後の泡の量と30秒後の泡の量とが変わらないものを最良(◎)、
30秒後の泡が消滅したものを悪(×)として評価した。
<Evaluation of injection performance>
Using the produced aerosol product, the contents were sprayed, and the sprayed state, dripping property, foaming property, foaminess, and the propriety of jetting in the upside down direction were evaluated visually. Each evaluation item was evaluated in four stages: best ((), good (◯), slightly bad (△), and bad (×).
The spray state was evaluated as the best (◎) when it became a fine mist at the time of injection, and bad (X) when it was not able to be injected.
The dripping property was evaluated as follows. That is, a 18cm x 18cm frosted glass plate is set up vertically, sprayed once toward the glass plate from a position 20cm away from the horizontal distance, and sprayed several times until the glass surface has no gaps. Continue to observe the dripping on the glass surface for each injection, and the best one that does not cause dripping even after multiple injections (◎) The one that causes dripping even after one injection is bad ( X).
The foaming property was evaluated as the best (◎) when the amount of foam after 1 second of injection was the best (◎) and bad (×) when there was no foam.
The best foam is that the amount of foam after 1 second and the amount of foam after 30 seconds do not change (◎),
A case where bubbles disappeared after 30 seconds was evaluated as bad (×).
<流動性の評価>
流動性の評価を上下反対向きでの噴射の可否で実施した。エアゾール容器を上下反対にして噴射したときに連続噴射できるものを最良(◎)、噴射自体はできるものを良(○)、噴射できずに流れるものを悪(×)として評価した。
<Evaluation of fluidity>
The evaluation of fluidity was carried out based on the possibility of injection in the opposite direction. When the aerosol container was turned upside down, it was evaluated as best (◎) if it could be continuously sprayed, good (◯) if it could be sprayed, and bad (x) if it couldn't be sprayed.
各実施例と比較例6,7との比較から、非イオン界面活性剤を0.15〜1.5重量%含有する後発泡性エアゾール組成物を用いたエアゾール製品は、後発泡性及び良好な噴射性能を有することが認識できる。 From the comparison between each Example and Comparative Examples 6 and 7, the aerosol product using the post-foaming aerosol composition containing 0.15 to 1.5% by weight of the nonionic surfactant was found to have good post-foaming property and good It can be recognized that it has injection performance.
本発明の後発泡性エアゾール組成物及びエアゾール製品は、化粧品用途、医薬品用途、防虫殺虫剤用途、一般家庭用品用途などで好適に用いられ得る。具体的には、ヘアスプレー、シェービングフォーム、ゴキブリ用殺虫剤などとして好適に用いられ得る。 The post-foaming aerosol composition and aerosol product of the present invention can be suitably used for cosmetics, pharmaceuticals, insecticides, general household products, and the like. Specifically, it can be suitably used as a hair spray, shaving foam, insecticide for cockroaches and the like.
Claims (3)
前記非イオン界面活性剤が0.15〜1.5重量%含有されていることを特徴とする後発泡性エアゾール組成物。 Post-foaming aerosol containing cellulose fine particles having an average particle size of 5 μm or less, an average degree of polymerization (DP) of 100 or less, and a crystallization ratio of 50% or less, a nonionic surfactant, and a propellant A composition comprising:
A post-foaming aerosol composition comprising 0.15 to 1.5% by weight of the nonionic surfactant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008177745A JP2010018645A (en) | 2008-07-08 | 2008-07-08 | Post-foaming aerosol composition and aerosol product using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008177745A JP2010018645A (en) | 2008-07-08 | 2008-07-08 | Post-foaming aerosol composition and aerosol product using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2010018645A true JP2010018645A (en) | 2010-01-28 |
Family
ID=41703875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008177745A Withdrawn JP2010018645A (en) | 2008-07-08 | 2008-07-08 | Post-foaming aerosol composition and aerosol product using the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2010018645A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013237830A (en) * | 2011-12-28 | 2013-11-28 | Sanei Gen Ffi Inc | Bubble composition |
CN105982822A (en) * | 2015-03-20 | 2016-10-05 | 富士胶片株式会社 | Aerosol comestic |
JP2017114915A (en) * | 2017-03-30 | 2017-06-29 | 花王株式会社 | Aerosol cosmetics |
WO2017217511A1 (en) * | 2016-06-16 | 2017-12-21 | 日本製紙株式会社 | Foamable aerosol composition |
JP2020002068A (en) * | 2018-06-28 | 2020-01-09 | 株式会社ダイゾー | Post-foamable composition and discharge product |
JP7409808B2 (en) | 2019-09-10 | 2024-01-09 | 株式会社ダイゾー | Foaming aerosol composition |
-
2008
- 2008-07-08 JP JP2008177745A patent/JP2010018645A/en not_active Withdrawn
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013237830A (en) * | 2011-12-28 | 2013-11-28 | Sanei Gen Ffi Inc | Bubble composition |
CN105982822A (en) * | 2015-03-20 | 2016-10-05 | 富士胶片株式会社 | Aerosol comestic |
CN105982822B (en) * | 2015-03-20 | 2021-03-16 | 富士胶片株式会社 | Aerosol cosmetic product |
KR20190017987A (en) | 2016-06-16 | 2019-02-20 | 닛뽄세이시가부시끼가이샤 | Foamable aerosol composition |
JP2017222610A (en) * | 2016-06-16 | 2017-12-21 | 日本製紙株式会社 | Foaming aerosol composition |
CN109310614A (en) * | 2016-06-16 | 2019-02-05 | 日本制纸株式会社 | Foaminess aerosol combination |
WO2017217511A1 (en) * | 2016-06-16 | 2017-12-21 | 日本製紙株式会社 | Foamable aerosol composition |
KR20210037010A (en) | 2016-06-16 | 2021-04-05 | 닛뽄세이시가부시끼가이샤 | Foamable aerosol composition |
KR102503314B1 (en) * | 2016-06-16 | 2023-02-28 | 닛뽄세이시가부시끼가이샤 | Foamable aerosol composition |
US11648189B2 (en) | 2016-06-16 | 2023-05-16 | Nippon Paper Industries Co., Ltd. | Foamable aerosol composition |
JP2017114915A (en) * | 2017-03-30 | 2017-06-29 | 花王株式会社 | Aerosol cosmetics |
JP2020002068A (en) * | 2018-06-28 | 2020-01-09 | 株式会社ダイゾー | Post-foamable composition and discharge product |
JP7409808B2 (en) | 2019-09-10 | 2024-01-09 | 株式会社ダイゾー | Foaming aerosol composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7094448B2 (en) | Spray pack | |
KR101512886B1 (en) | Viscous composition | |
JP5269513B2 (en) | Spray composition and spray spraying apparatus using the same | |
JP4662637B2 (en) | Emulsification system and emulsion | |
JP4236064B2 (en) | Cosmetic composition containing low crystalline cellulose fine particles | |
EP1577361A1 (en) | Spraying composition | |
US20160175228A1 (en) | A cream-like solid agarose-in-water gel particles suspension as an intermediate cosmetics product | |
KR20010031274A (en) | Use of substantially amorphous cellulose nanofibrils associated with a polyhydroxylated organic compound in cosmetic formulations | |
JP2010018645A (en) | Post-foaming aerosol composition and aerosol product using the same | |
JP6100572B2 (en) | Spray-type cosmetics | |
JP6425518B2 (en) | Spray composition and spray apparatus using the same | |
JP2019011287A (en) | Cosmetic composition | |
KR20090057044A (en) | Emulsion composition with good feeling of use | |
CN1347307A (en) | Cosmetic preparations | |
JP2013508359A (en) | Method for wetting powders containing benzoyl peroxide | |
JP7100550B2 (en) | Composition for spray | |
RU2470626C2 (en) | Use of agglomerate-forming hydroxyethyl cellulose for producing pharmaceutical agents, personal hygiene products and household supplies | |
JPH11279522A (en) | Preparation of gel-like product | |
JP6121887B2 (en) | Spray-type cosmetics | |
JP7326076B2 (en) | Aerosol composition | |
WO2016169000A1 (en) | A foamable personal care composition and the use thereof | |
WO2020066163A1 (en) | Particle-containing composition, composition for spray, and gel-like composition | |
TW200411022A (en) | Composition for spray coating | |
US20140148407A1 (en) | Aqueous gels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20111004 |